In vitro 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia

Biological Psychiatry

Volumn 42, Issue 5, 1997, Pages 359-366

  Omori, Masao ^a,b   Pearce, John ^a   Komoroski, Richard A ^a   Griffin, W Sue T ^a   Mrak, Robert E ^a   Husain, Muhammad M ^a   Karson, Craig N ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

1H Magnetic resonance spectroscopy; Brain metabolism; N acetyl aspartate; Postmortem; Schizophrenia; Thalamus

Indexed keywords

AMINO ACID; GLUTAMIC ACID; N ACETYLASPARTIC ACID; VALINE; 4 AMINOBUTYRIC ACID; ASPARTIC ACID; DRUG DERIVATIVE; N-ACETYLASPARTATE;

ADULT; AGED; ARTICLE; BRAIN METABOLISM; CADAVER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA; THALAMUS; BRAIN CORTEX; BRAIN LEVEL; CEREBELLUM; CHEMISTRY; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACIDS; ASPARTIC ACID; BRAIN CHEMISTRY; CEREBELLUM; CEREBRAL CORTEX; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; SCHIZOPHRENIA; THALAMUS;

EID: 0030610611     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00409-X     Document Type: Article

References (35)

1. Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC, Freedman R (1982): Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 17:639-654.
2. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev. Washington, DC: American Psychiatric Press.
3. Andreasen NC, Ehrhardt JC, Swayze VW II, et al (1990): Magnetic resonance imaging of the brains in schizophrenia: The pathophysiologic significance of structural abnormalities. Arch Gen Psychiatry 47:35-44.
4. Andreasen NC, Arndt S, Swayze V II, et al (1994): Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 266:294-298.
5. Bogerts B (1993): Recent advances in the neuropathology of schizophrenia. Schizophr Bull 19:431-445.
6. Buchsbaum MS, Someya T, Teng CY, et al (1996): PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry 153:191-199.
7. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: Clinical, neurodevelopmental, and cognitive correlates. Biol Psychiatry 36:792-800.
8. 31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia. Biol Psychiatry 32:26-32.
9. 1H magnetic resonance spectroscopy study. Abstracts of the First Symposium on Magnetic Resonance Applied to Psychiatry, Rouffach, France p 52.
10. Corey-Bloom J, Jernigan T, Archibald S, Harris MJ, Jeste DV (1995): Quantitative magnetic resonance imaging of the brain in late-life schizophrenia. Am J Psychiatry 152:447-449.
11. 31Phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia. Biol Psychiatry 36:503-510.
12. Deicken RF. Calabrese G, Merrin EL, Fein G, Weiner MW (1995): Basal ganglia phosphorus metabolism in chronic schizophrenia. Am J Psychiatry 152:126-129.
13. Erwin RJ, Mawhinney-Hee M, Gur RC, Gur RE (1991): Midlatency auditory evoked responses in schizophrenia. Biol Psychiatry 30:430-442.
14. Feighner JP, Robins E, Guze SB, Woodruff RA Jr, Winokur G, Munoz R (1972): Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26:57-63.
15. Karson CN, Casanova MF, Kleinman JE, Griffin WST (1993): Choline acetyltransferase in schizophrenia. Am J Psrchiatry 150:455-459.
16. Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmuller B (1980): Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 20: 379-382.
17. Klunk WE, Panchalingam K, Moossy J, McClure RJ, Pettegrew JW (1992): N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: A preliminary proton nuclear magnetic resonance study. Neurology 42:1578-1585.
18. Koller KJ, Zaczek R, Coyle JT (1984): N-acetyl-aspartyl-glutamate: Regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem 43:1136-1142.
19. 1H NMR spectroscopy study of schizophrenics. Abstracts of the Third Meeting of the Society of Magnetic Resonance, Nice, France.
20. Maier M (1994): Hippocampal neuronal depletion in schizophrenia measured by proton MRS. Abstracts of the First Symposium on Magnetic Resonance Applied to Psychiatry, Rouffach, France p 23.
21. McDowd JM, Filion DL, Harris MJ, Braff DL (1993): Sensory gating and inhibitory function in late-life schizophrenia. Schizophr Bull 19:733-746.
22. Mirra SS, Heyman A, McKeel D, et al, and participating CERAD Neuropathologists (1991): The consortium to establish a registry for Alzheimer's disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486.
23. 1H nuclear magnetic resonance study of the temporoparietal cortex of Alzheimer brains. Exp Brain Res 102:503-510.
24. Nadler JV, Cooper JR (1972): N-acetyl-L-aspartic acid content of human neural tumors and bovine peripheral nervous tissues. J Neurochem 19:313-319.
25. 1H-MRS) of the hippocampal formation in schizophrenia: A pilot study. Br J Psychiatry 165:481-485.
26. Olney JW (1989): Excitatory amino acids and neuropsychiatrie disorders. Biol Psychiatry 26:505-525.
27. Pakkenberg B (1990): Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 47:1023-1028.
28. Petroff OAC, Ogino T, Alger JR (1988): High-resolution proton magnetic resonance spectroscopy of rabbit brain: Regional metabolite levels and postmortem changes. J Neurochem 51:163-171.
29. Petroff OAC, Spencer DD, Alger JR, Prichard JW (1989): High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology 39:1197-1202.
30. Pettegrew JW, Keshavan M, Panchalingam K, et al (1991): Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug naive schizophrenics. Arch Gen Psychiatry 48:563-568.
31. Renshaw PF, Yurgelun-Todd DA, Tohen M, Gruber S, Cohen BM (1995): Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. Am J Psychiatry 152:444-446.
32. Salzman S, Endicott J, Clayton P, Winokur G (eds) (1983): Diagnostic Evaluation after Death (DEAD). Rockville, MD: NIMH Neurosciences Research Branch.
33. Stanley JA, Drost DJ, Williamson PC, Carr TJ (1995): In vivo proton MRS study of glutamate and schizophrenia. In Nasrallah HA, Pettegrew JW (eds), NMR Spectroscopy in Psychiatric Brain Disorders. Progress in Psychiatry 47, Washington DC: American Psychiatric Press, pp 21-44.
34. Tsai G, Passani LA, Slusher BS, et al (1995): Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 52:829-836.
35. 1H MRS of N-acetyl aspartate (NAA) in the temporal lobes in schizophrenia. Biol Psychiatry 33:45A.